KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Change in Intangibles (2016 - 2020)

Historic Change in Intangibles for Pfizer (PFE) over the last 8 years, with Q3 2020 value amounting to $38.0 million.

  • Pfizer's Change in Intangibles fell 6082.47% to $38.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $125.0 million, marking a year-over-year decrease of 7334.75%. This contributed to the annual value of $539.0 million for FY2020, which is 2894.74% up from last year.
  • Latest data reveals that Pfizer reported Change in Intangibles of $38.0 million as of Q3 2020, which was down 6082.47% from $1.0 million recorded in Q2 2020.
  • In the past 5 years, Pfizer's Change in Intangibles registered a high of $158.0 million during Q1 2019, and its lowest value of $1.0 million during Q2 2020.
  • In the last 5 years, Pfizer's Change in Intangibles had a median value of $76.5 million in 2016 and averaged $74.1 million.
  • As far as peak fluctuations go, Pfizer's Change in Intangibles soared by 182000.0% in 2016, and later crashed by 9908.26% in 2020.
  • Quarter analysis of 5 years shows Pfizer's Change in Intangibles stood at $80.0 million in 2016, then dropped by 8.75% to $73.0 million in 2017, then skyrocketed by 43.84% to $105.0 million in 2018, then crashed by 48.57% to $54.0 million in 2019, then dropped by 29.63% to $38.0 million in 2020.
  • Its last three reported values are $38.0 million in Q3 2020, $1.0 million for Q2 2020, and $32.0 million during Q1 2020.